documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
38 rows where docket_id = "FDA-1992-N-0049" sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: title, subtype, posted_date, posted_month, last_modified, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)
document_type 5
- Supporting & Related Material 34
- Notice 1
- Other 1
- Proposed Rule 1
- Rule 1
agency_id 1
- FDA 38
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-1992-N-0049-0034 | FDA | Topical Drug Containing Benzoyl Peroxide; Additional Labeling FDA-1992-N-0049 | Reference 12 - "Comment No. LET20, 1981N-0114" - [Classification of Benzoyl Peroxide as Safe and Effective and Revision of Labeling to Drug Facts Format; Topical Acne Drug Products for Over-the-Counter Human Use; Final Rule] | Supporting & Related Material | BKG-Background Material | 2010-03-08T05:00:00Z | 2010 | 3 | 2010-03-08T06:40:41Z | 0 | 0 | 0900006480ab4d30 | |||
| FDA-1992-N-0049-0031 | FDA | Topical Drug Containing Benzoyl Peroxide; Additional Labeling FDA-1992-N-0049 | Reference 5 - "International Conference On Harmonisation of Technical Requirements For Registration of Pharmaceuticals For Human Use" - [Classification of Benzoyl Peroxide as Safe and Effective and Revision of Labeling to Drug Facts Format; Topical Acne Drug Products for Over-the-Counter Human Use; Final Rule] | Supporting & Related Material | BKG-Background Material | 2010-03-08T05:00:00Z | 2010 | 3 | 2010-03-08T06:40:36Z | 0 | 0 | 0900006480ab48e8 | |||
| FDA-1992-N-0049-0033 | FDA | Topical Drug Containing Benzoyl Peroxide; Additional Labeling FDA-1992-N-0049 | Reference 11 - "Comment No. LET19, 1981N-0114" - [Classification of Benzoyl Peroxide as Safe and Effective and Revision of Labeling to Drug Facts Format; Topical Acne Drug Products for Over-the-Counter Human Use; Final Rule] | Supporting & Related Material | BKG-Background Material | 2010-03-08T05:00:00Z | 2010 | 3 | 2010-03-08T06:40:39Z | 0 | 0 | 0900006480ab4d2e | |||
| FDA-1992-N-0049-0035 | FDA | Topical Drug Containing Benzoyl Peroxide; Additional Labeling FDA-1992-N-0049 | Reference 13 - "Comment No. LET21, 1981N-0114" - [Classification of Benzoyl Peroxide as Safe and Effective and Revision of Labeling to Drug Facts Format; Topical Acne Drug Products for Over-the-Counter Human Use; Final Rule] | Supporting & Related Material | BKG-Background Material | 2010-03-08T05:00:00Z | 2010 | 3 | 2010-03-08T06:40:42Z | 0 | 0 | 0900006480ab4d32 | |||
| FDA-1992-N-0049-0042 | FDA | Topical Drug Containing Benzoyl Peroxide; Additional Labeling FDA-1992-N-0049 | Reference 22 - "FDA Labeling Cost Model, Final Report" - [Classification of Benzoyl Peroxide as Safe and Effective and Revision of Labeling to Drug Facts Format; Topical Acne Drug Products for Over-the-Counter Human Use; Final Rule] | Supporting & Related Material | BKG-Background Material | 2010-03-08T05:00:00Z | 2010 | 3 | 2010-03-08T06:40:53Z | 0 | 0 | 0900006480ab4eaa | |||
| FDA-1992-N-0049-0039 | FDA | Topical Drug Containing Benzoyl Peroxide; Additional Labeling FDA-1992-N-0049 | Reference 17 - "Comment No. C4, NDMA 1992N-0311" - [Classification of Benzoyl Peroxide as Safe and Effective and Revision of Labeling to Drug Facts Format; Topical Acne Drug Products for Over-the-Counter Human Use; Final Rule] | Supporting & Related Material | BKG-Background Material | 2010-03-08T05:00:00Z | 2010 | 3 | 2010-03-08T06:40:48Z | 0 | 0 | 0900006480ab4d3e | |||
| FDA-1992-N-0049-0036 | FDA | Topical Drug Containing Benzoyl Peroxide; Additional Labeling FDA-1992-N-0049 | Reference 14 - "Comment No. LET22, 1981N-0114" - [Classification of Benzoyl Peroxide as Safe and Effective and Revision of Labeling to Drug Facts Format; Topical Acne Drug Products for Over-the-Counter Human Use; Final Rule] | Supporting & Related Material | BKG-Background Material | 2010-03-08T05:00:00Z | 2010 | 3 | 2010-03-08T06:40:44Z | 0 | 0 | 0900006480ab4d3b | |||
| FDA-1992-N-0049-0032 | FDA | Topical Drug Containing Benzoyl Peroxide; Additional Labeling FDA-1992-N-0049 | Reference 10 - "Comment No. RPT3, 1981N-0114" - [Classification of Benzoyl Peroxide as Safe and Effective and Revision of Labeling to Drug Facts Format; Topical Acne Drug Products for Over-the-Counter Human Use; Final Rule] | Supporting & Related Material | BKG-Background Material | 2010-03-08T05:00:00Z | 2010 | 3 | 2010-03-08T06:40:38Z | 0 | 0 | 0900006480ab4d2c | |||
| FDA-1992-N-0049-0040 | FDA | Topical Drug Containing Benzoyl Peroxide; Additional Labeling FDA-1992-N-0049 | Reference 18 - "Comment No. C1, Target Health Inc., 1992N-0311" - [Classification of Benzoyl Peroxide as Safe and Effective and Revision of Labeling to Drug Facts Format; Topical Acne Drug Products for Over-the-Counter Human Use; Final Rule] | Supporting & Related Material | BKG-Background Material | 2010-03-08T05:00:00Z | 2010 | 3 | 2010-03-08T06:40:50Z | 0 | 0 | 0900006480ab4d3f | |||
| FDA-1992-N-0049-0029 | FDA | Topical Drug Containing Benzoyl Peroxide; Additional Labeling FDA-1992-N-0049 | List of References - [Classification of Benzoyl Peroxide as Safe and Effective and Revision of Labeling to Drug Facts Format; Topical Acne Drug Products for Over-the-Counter Human Use; Final Rule] | Supporting & Related Material | BKG-Background Material | 2010-03-08T05:00:00Z | 2010 | 3 | 2010-03-08T06:40:33Z | 0 | 0 | 0900006480ab488e | |||
| FDA-1992-N-0049-0037 | FDA | Topical Drug Containing Benzoyl Peroxide; Additional Labeling FDA-1992-N-0049 | Reference 15 - "Comment No. RPT4, 1981N-0114" - [Classification of Benzoyl Peroxide as Safe and Effective and Revision of Labeling to Drug Facts Format; Topical Acne Drug Products for Over-the-Counter Human Use; Final Rule] | Supporting & Related Material | BKG-Background Material | 2010-03-08T05:00:00Z | 2010 | 3 | 2010-03-08T06:40:45Z | 0 | 0 | 0900006480ab4d3c | |||
| FDA-1992-N-0049-0030 | FDA | Topical Drug Containing Benzoyl Peroxide; Additional Labeling FDA-1992-N-0049 | Reference 3 - "Comment No. C4, 1981N-114A" - [Classification of Benzoyl Peroxide as Safe and Effective and Revision of Labeling to Drug Facts Format; Topical Acne Drug Products for Over-the-Counter Human Use; Final Rule] | Supporting & Related Material | BKG-Background Material | 2010-03-08T05:00:00Z | 2010 | 3 | 2010-03-08T06:40:35Z | 0 | 0 | 0900006480ab48e5 | |||
| FDA-1992-N-0049-0041 | FDA | Topical Drug Containing Benzoyl Peroxide; Additional Labeling FDA-1992-N-0049 | Reference 21 - "Comment No. C2, Wholesale Druggists' Association, 1992N-0311" - [Classification of Benzoyl Peroxide as Safe and Effective and Revision of Labeling to Drug Facts Format; Topical Acne Drug Products for Over-the-Counter Human Use; Final Rule] | Supporting & Related Material | BKG-Background Material | 2010-03-08T05:00:00Z | 2010 | 3 | 2010-03-08T06:40:51Z | 0 | 0 | 0900006480ab4ea5 | |||
| FDA-1992-N-0049-0038 | FDA | Topical Drug Containing Benzoyl Peroxide; Additional Labeling FDA-1992-N-0049 | Reference 16 - "Comment No. C3, American Academy of Dermatology" - [Classification of Benzoyl Peroxide as Safe and Effective and Revision of Labeling to Drug Facts Format; Topical Acne Drug Products for Over-the-Counter Human Use; Final Rule] | Supporting & Related Material | BKG-Background Material | 2010-03-08T05:00:00Z | 2010 | 3 | 2010-03-08T06:40:47Z | 0 | 0 | 0900006480ab4d3d | |||
| FDA-1992-N-0049-0028 | FDA | Topical Drug Containing Benzoyl Peroxide; Additional Labeling FDA-1992-N-0049 | Classification of Benzoyl Peroxide as Safe and Effective and Revision of Labeling to Drug Facts Format; Topical Acne Drug Products for Over-the-Counter Human Use; Final Rule | Rule | NFR-Notice of Final Rule | 2010-03-04T05:00:00Z | 2010 | 3 | 2010-03-04T05:00:00Z | 2010-03-08T06:09:32Z | 0 | 0 | 0900006480ab4f84 | ||
| FDA-1992-N-0049-0023 | FDA | Topical Drug Containing Benzoyl Peroxide; Additional Labeling FDA-1992-N-0049 | NDMA (Nonprescription Drug Manufacturers Association - Request for Extension of Comment Due Date | Other | EXT-Request for Extension Comment Due Date | 2010-02-25T05:00:00Z | 2010 | 2 | 2010-02-25T05:00:00Z | 2013-07-27T21:29:03Z | 0 | 0 | 090000648052bd03 | ||
| FDA-1992-N-0049-0002 | FDA | Topical Drug Containing Benzoyl Peroxide; Additional Labeling FDA-1992-N-0049 | Topical Drug Products Containing Benzoyl Peroxide; Required Labeling; Extension of Comment Period | Notice | NEC-Notice of Extension | 1995-06-07T04:00:00Z | 1995 | 6 | 1995-06-07T04:00:00Z | 1995-07-18T03:59:59Z | 2010-02-25T18:34:06Z | 0 | 0 | 090000648052bd0a | |
| FDA-1992-N-0049-0001 | FDA | Topical Drug Containing Benzoyl Peroxide; Additional Labeling FDA-1992-N-0049 | Topical Drug Products Containing Benzoyl Peroxide; Required Labeling | Proposed Rule | NPR-Notice of Proposed Rule-Making | 1995-02-23T05:00:00Z | 1995 | 2 | 1995-02-23T05:00:00Z | 1995-05-19T03:59:59Z | 2010-02-25T18:30:48Z | 0 | 0 | 090000648052bcf4 | |
| FDA-1992-N-0049-0022 | FDA | Topical Drug Containing Benzoyl Peroxide; Additional Labeling FDA-1992-N-0049 | Reference 13 - [Topical Drug Products Containing Benzoyl Peroxide; Required Labeling] - [Topical Drug Products Containing Benzoyl Peroxide; Required Labeling] | Supporting & Related Material | BKG-Background Material | 1995-02-17T05:00:00Z | 1995 | 2 | 2010-02-25T21:11:46Z | 0 | 0 | 090000648052bd26 | |||
| FDA-1992-N-0049-0004 | FDA | Topical Drug Containing Benzoyl Peroxide; Additional Labeling FDA-1992-N-0049 | Background Material | Supporting & Related Material | BKG-Background Material | 1995-02-17T05:00:00Z | 1995 | 2 | 2008-05-16T23:34:17Z | 0 | 0 | 090000648052bd0e | |||
| FDA-1992-N-0049-0009 | FDA | Topical Drug Containing Benzoyl Peroxide; Additional Labeling FDA-1992-N-0049 | Reference 2 - "Kurokawa, et al., Studies on the Promoting and Complete Carcinogenic Activities of Some Oxidizing Chemicals in Skin Carcinogensis" - [Topical Drug Products Containing Benzoyl Peroxide; Required Labeling] | Supporting & Related Material | BKG-Background Material | 1995-02-17T05:00:00Z | 1995 | 2 | 2010-02-25T20:47:08Z | 0 | 0 | 090000648052bd19 | |||
| FDA-1992-N-0049-0010 | FDA | Topical Drug Containing Benzoyl Peroxide; Additional Labeling FDA-1992-N-0049 | Reference 3 - [Topical Drug Products Containing Benzoyl Peroxide; Required Labeling] | Supporting & Related Material | BKG-Background Material | 1995-02-17T05:00:00Z | 1995 | 2 | 2010-02-25T21:06:34Z | 0 | 0 | 090000648052bd1a | |||
| FDA-1992-N-0049-0008 | FDA | Topical Drug Containing Benzoyl Peroxide; Additional Labeling FDA-1992-N-0049 | Reference 1 - "Slaga, et al., Skin Tumor-Promoting Activity of Benzoyl Peroxide, a Widely Used Free Radical-Generating Compound" - [Topical Drug Products Containing Benzoyl Peroxide; Required Labeling] | Supporting & Related Material | BKG-Background Material | 1995-02-17T05:00:00Z | 1995 | 2 | 2010-02-25T20:42:29Z | 0 | 0 | 090000648052bd18 | |||
| FDA-1992-N-0049-0007 | FDA | Topical Drug Containing Benzoyl Peroxide; Additional Labeling FDA-1992-N-0049 | FDA Memorandum to Dockets Management Branch, February 22, 1995, Public Administrative File for Proposal Rule - [Topical Drug Products Containing Benzoyl Peroxide; Required Labeling] | Supporting & Related Material | BKG-Background Material | 1995-02-17T05:00:00Z | 1995 | 2 | 2010-02-25T20:36:08Z | 0 | 0 | 090000648052bd17 | |||
| FDA-1992-N-0049-0018 | FDA | Topical Drug Containing Benzoyl Peroxide; Additional Labeling FDA-1992-N-0049 | Background Material | Supporting & Related Material | BKG-Background Material | 1995-02-17T05:00:00Z | 1995 | 2 | 2008-05-16T23:34:17Z | 0 | 0 | 090000648052bd22 | |||
| FDA-1992-N-0049-0013 | FDA | Topical Drug Containing Benzoyl Peroxide; Additional Labeling FDA-1992-N-0049 | Reference 1.2 - "Correspondence and Memoranda" - [Topical Drug Products Containing Benzoyl Peroxide; Required Labeling] | Supporting & Related Material | BKG-Background Material | 1995-02-17T05:00:00Z | 1995 | 2 | 2010-02-25T20:55:48Z | 0 | 0 | 090000648052bd1d | |||
| FDA-1992-N-0049-0017 | FDA | Topical Drug Containing Benzoyl Peroxide; Additional Labeling FDA-1992-N-0049 | Background Material | Supporting & Related Material | BKG-Background Material | 1995-02-17T05:00:00Z | 1995 | 2 | 2008-05-16T23:34:17Z | 0 | 0 | 090000648052bd21 | |||
| FDA-1992-N-0049-0005 | FDA | Topical Drug Containing Benzoyl Peroxide; Additional Labeling FDA-1992-N-0049 | Reference 10 - "Iversen, Carcinogenesis Studies with Benzoyl- Peroxide" - [Topical Drug Products Containing Benzoyl Peroxide; Required Labeling] | Supporting & Related Material | BKG-Background Material | 1995-02-17T05:00:00Z | 1995 | 2 | 2010-02-25T20:13:37Z | 0 | 0 | 090000648052bd12 | |||
| FDA-1992-N-0049-0012 | FDA | Topical Drug Containing Benzoyl Peroxide; Additional Labeling FDA-1992-N-0049 | Reference 17 - "Physicians' Desk Reference, 47th Edition" - [Topical Drug Products Containing Benzoyl Peroxide; Required Labeling] | Supporting & Related Material | BKG-Background Material | 1995-02-17T05:00:00Z | 1995 | 2 | 2010-02-25T20:53:18Z | 0 | 0 | 090000648052bd1c | |||
| FDA-1992-N-0049-0015 | FDA | Topical Drug Containing Benzoyl Peroxide; Additional Labeling FDA-1992-N-0049 | Background Material | Supporting & Related Material | BKG-Background Material | 1995-02-17T05:00:00Z | 1995 | 2 | 2008-05-16T23:34:17Z | 0 | 0 | 090000648052bd1f | |||
| FDA-1992-N-0049-0011 | FDA | Topical Drug Containing Benzoyl Peroxide; Additional Labeling FDA-1992-N-0049 | Reference 16 - "Hogan, et al., Studies on the Promoting and Complete Carcinogenic Activities of Some Oxidizing Chemicals in Skin Carcinogensis" - [Topical Drug Products Containing Benzoyl Peroxide; Required Labeling] | Supporting & Related Material | BKG-Background Material | 1995-02-17T05:00:00Z | 1995 | 2 | 2010-02-25T20:51:17Z | 0 | 0 | 090000648052bd1b | |||
| FDA-1992-N-0049-0003 | FDA | Topical Drug Containing Benzoyl Peroxide; Additional Labeling FDA-1992-N-0049 | Background Material | Supporting & Related Material | BKG-Background Material | 1995-02-17T05:00:00Z | 1995 | 2 | 2008-05-16T23:34:17Z | 0 | 0 | 090000648052bd0c | |||
| FDA-1992-N-0049-0016 | FDA | Topical Drug Containing Benzoyl Peroxide; Additional Labeling FDA-1992-N-0049 | Background Material | Supporting & Related Material | BKG-Background Material | 1995-02-17T05:00:00Z | 1995 | 2 | 2008-05-16T23:34:17Z | 0 | 0 | 090000648052bd20 | |||
| FDA-1992-N-0049-0014 | FDA | Topical Drug Containing Benzoyl Peroxide; Additional Labeling FDA-1992-N-0049 | Reference 7 - "Comments C31, PR1, & PR2" - [Topical Drug Products Containing Benzoyl Peroxide; Required Labeling] | Supporting & Related Material | BKG-Background Material | 1995-02-17T05:00:00Z | 1995 | 2 | 2010-02-25T20:59:44Z | 0 | 0 | 090000648052bd1e | |||
| FDA-1992-N-0049-0020 | FDA | Topical Drug Containing Benzoyl Peroxide; Additional Labeling FDA-1992-N-0049 | Background Material | Supporting & Related Material | BKG-Background Material | 1995-02-17T05:00:00Z | 1995 | 2 | 2008-05-16T23:34:17Z | 0 | 0 | 090000648052bd24 | |||
| FDA-1992-N-0049-0021 | FDA | Topical Drug Containing Benzoyl Peroxide; Additional Labeling FDA-1992-N-0049 | Background Material | Supporting & Related Material | BKG-Background Material | 1995-02-17T05:00:00Z | 1995 | 2 | 2008-05-16T23:34:17Z | 0 | 0 | 090000648052bd25 | |||
| FDA-1992-N-0049-0019 | FDA | Topical Drug Containing Benzoyl Peroxide; Additional Labeling FDA-1992-N-0049 | Background Material | Supporting & Related Material | BKG-Background Material | 1995-02-17T05:00:00Z | 1995 | 2 | 2008-05-16T23:34:17Z | 0 | 0 | 090000648052bd23 | |||
| FDA-1992-N-0049-0006 | FDA | Topical Drug Containing Benzoyl Peroxide; Additional Labeling FDA-1992-N-0049 | Reference 11 - "Iversen, Skin Tumorigenesis and Carcinogenesis Studies With7,12-Dimethylbenz[a]anthracene, Ultraviolet Light, Benzoyl Peroxide (Panoxyl gel 5%) and Ointment Gel " - [Topical Drug Products Containing Benzoyl Peroxide; Required Labeling] | Supporting & Related Material | BKG-Background Material | 1995-02-17T05:00:00Z | 1995 | 2 | 2010-02-25T20:24:04Z | 0 | 0 | 090000648052bd14 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);